Grey zone in the Barcelona Clinic Liver Cancer Classification for hepatocellular carcinoma: Surgeons' perspective

World Journal of Gastroenterology

Volumn 21, Issue 27, 2015, Pages 8256-8261

  Yang, Tian ^a   Lau, Wan Yee ^a,b   Zhang, Han ^a   Huang, Bin ^a   Lu, Jun Hua ^a   Wu, Meng Chao ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Prince of Wales Hospital   (Hong Kong)

Author keywords

Barcelona Clinic Liver Cancer Classification; Hepatectomy; Hepatocellular carcinoma; Prognosis; Staging system; Treatment

Indexed keywords

SORAFENIB;

ARTICLE; BARCELONA CLINIC LIVER CANCER CLASSIFICATION; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; CHILD PUGH SCORE; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LONG TERM SURVIVAL; MEDICAL SOCIETY; MULTICENTER STUDY (TOPIC); MULTIMODALITY CANCER THERAPY; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; RADIOFREQUENCY ABLATION; ADULT; ALGORITHM; CARCINOMA, HEPATOCELLULAR; CLASSIFICATION; CLINICAL PATHWAY; DECISION SUPPORT SYSTEM; FEMALE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATIENT SELECTION; PREDICTIVE VALUE; PROTOCOL COMPLIANCE; RISK ASSESSMENT; RISK FACTOR; SURGEON; X-RAY COMPUTED TOMOGRAPHY;

ADULT; ALGORITHMS; CARCINOMA, HEPATOCELLULAR; CRITICAL PATHWAYS; DECISION SUPPORT TECHNIQUES; FEMALE; GUIDELINE ADHERENCE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PRACTICE PATTERNS, PHYSICIANS'; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SURGEONS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84938097114     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i27.8256     Document Type: Article

References (46)

1. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet 2012; 379: 1245-1255 [PMID: 22353262 DOI: 10.1016/S0140-6736(11)61347-0]
2. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9-29 [PMID: 24399786 DOI: 10.3322/caac.21208]
3. El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011; 365: 1118-1127 [PMID: 21992124 DOI: 10.1056/NEJMra1001683]
4. Maluccio M, Covey A. Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J Clin 2012; 62: 394-399 [PMID: 23070690 DOI: 10.3322/caac.21161]
5. Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19: 329-338 [PMID: 10518312 DOI: 10.1055/s-2007-1007122]
6. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodés J. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-430 [PMID: 11592607]
7. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022 [PMID: 21374666 DOI: 10.1002/hep.24199]
8. Torzilli G, Belghiti J, Kokudo N, Takayama T, Capussotti L, Nuzzo G, Vauthey JN, Choti MA, De Santibanes E, Donadon M, Morenghi E, Makuuchi M. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group. Ann Surg 2013; 257: 929-937 [PMID: 23426336 DOI: 10.1097/SLA.0b013e31828329b8]
9. Sørensen JB, Klee M, Palshof T, Hansen HH. Performance status assessment in cancer patients. An inter-observer variability study. Br J Cancer 1993; 67: 773-775 [PMID: 8471434]
10. Ikenaga N, Chijiiwa K, Otani K, Ohuchida J, Uchiyama S, Kondo K. Clinicopathologic characteristics of hepatocellular carcinoma with bile duct invasion. J Gastrointest Surg 2009; 13: 492-497 [PMID: 19011945 DOI: 10.1007/s11605-008-0751-0]
11. Qin LX, Tang ZY. Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis. World J Gastroenterol 2003; 9: 385-391 [PMID: 12632482]
12. Lai EC, Lau WY. Hepatocellular carcinoma presenting with obstructive jaundice. ANZ J Surg 2006; 76: 631-636 [PMID: 16813631 DOI: 10.1111/j.1445-2197.2006.03794.x]
13. Lau WY, Leung JW, Li AK. Management of hepatocellular carcinoma presenting as obstructive jaundice. Am J Surg 1990; 160: 280-282 [PMID: 2168129]
14. Yang T, Lin C, Zhai J, Shi S, Zhu M, Zhu N, Lu JH, Yang GS, Wu MC. Surgical resection for advanced hepatocellular carcinoma according to Barcelona Clinic Liver Cancer (BCLC) staging. J Cancer Res Clin Oncol 2012; 138: 1121-1129 [PMID: 22402598 DOI: 10.1007/s00432-012-1188-0]
15. Lai EC, Lau WY. Spontaneous rupture of hepatocellular carcinoma: a systematic review. Arch Surg 2006; 141: 191-198 [PMID: 16490898 DOI: 10.1001/archsurg.141.2.191]
16. Liu CL, Fan ST, Lo CM, Tso WK, Poon RT, Lam CM, Wong J. Management of spontaneous rupture of hepatocellular carcinoma: single-center experience. J Clin Oncol 2001; 19: 3725-3732 [PMID: 11533094]
17. Yeh CN, Lee WC, Jeng LB, Chen MF, Yu MC. Spontaneous tumour rupture and prognosis in patients with hepatocellular carcinoma. Br J Surg 2002; 89: 1125-1129 [PMID: 12190677]
18. Buczkowski AK, Kim PT, Ho SG, Schaeffer DF, Lee SI, Owen DA, Weiss AH, Chung SW, Scudamore CH. Multidisciplinary management of ruptured hepatocellular carcinoma. J Gastrointest Surg 2006; 10: 379-386 [PMID: 16504883]
19. Lai EC, Wu KM, Choi TK, Fan ST, Wong J. Spontaneous ruptured hepatocellular carcinoma. An appraisal of surgical treatment. Ann Surg 1989; 210: 24-28 [PMID: 2545172]
20. Leung KL, Lau WY, Lai PB, Yiu RY, Meng WC, Leow CK. Spontaneous rupture of hepatocellular carcinoma: conservative management and selective intervention. Arch Surg 1999; 134: 1103-1107 [PMID: 10522855]
21. Yang T, Sun YF, Zhang J, Lau WY, Lai EC, Lu JH, Shen F, Wu MC. Partial hepatectomy for ruptured hepatocellular carcinoma. Br J Surg 2013; 100: 1071-1079 [PMID: 23754648 DOI: 10.1002/bjs.9167]
22. Shimada R, Imamura H, Makuuchi M, Soeda J, Kobayashi A, Noike T, Miyagawa S, Kawasaki S. Staged hepatectomy after emergency transcatheter arterial embolization for ruptured hepatocellular carcinoma. Surgery 1998; 124: 526-535 [PMID: 9736905]
23. Mazzaferro V, Roayaie S, Poon R, Majno PE. Dissecting EASL/AASLD Recommendations With a More Careful Knife: A Comment on "Surgical Misinterpretation" of the BCLC Staging System. Ann Surg 2015; 262: e17-e18 [PMID: 24368644 DOI: 10.1097/SLA.0000000000000398]
24. Bruix J, Fuster J. A Snapshot of the Effective Indications and Results of Surgery for Hepatocellular Carcinoma in Tertiary Referral Centers: Is It Adherent to the EASL/AASLD Recommendations? An Observational Study of the HCC East-West Study Group. Ann Surg 2015; 262: e30 [PMID: 24374519 DOI: 10.1097/SLA.0000000000000381]
25. Torzilli G, Belghiti J, Kokudo N, Takayama T, Capussotti L, Nuzzo G, Vauthey JN, Choti MA, De Santibanes E, Donadon M, Makuuchi M. Reply to Letter: "Dissecting EASL/AASLD Recommendations With a More Careful Knife: A Comment on 'Surgical Misinterpretation' of the BCLC Staging System": Real Misinterpretation or Lack of Clarity Within the BCLC? Ann Surg 2015; 262: e18-e19 [PMID: 24263335 DOI: 10.1097/ SLA.0000000000000383]
26. Torzilli G, Belghiti J, Kokudo N, Takayama T, Capussotti L, Nuzzo G, Vauthey JN, Choti MA, De Santibanes E, Donadon M, Makuuchi M. Reply to Letter: "A Snapshot of the Effective Indications and Results of Surgery for Hepatocellular Carcinoma in Tertiary Referral Centers: Is It Adherent to the EASL/AASLD Recommendations? An Observational Study of the HCC East-West Study Group": When the Study Setting "Ignores" the Patients. Ann Surg 2015; 262: e30-e31 [PMID: 24253157 DOI: 10.1097/SLA.0000000000000382]
27. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236 [PMID: 16250051]
28. European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56: 908-943 [PMID: 22424438 DOI: 10.1016/j.jhep.2011.12.001]
29. List MA, D'Antonio LL, Cella DF, Siston A, Mumby P, Haraf D, Vokes E. The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity. Cancer 1996; 77: 2294-2301 [PMID: 8635098]
30. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002; 35: 519-524 [PMID: 11870363 DOI: 10.1053/jhep.2002.32089]
31. Bruix J, Llovet JM. Major achievements in hepatocellular carcinoma. Lancet 2009; 373: 614-616 [PMID: 19231618 DOI: 10.1016/S0140-6736(09)60381-0]
32. de Lope CR, Tremosini S, Forner A, Reig M, Bruix J. Management of HCC. J Hepatol 2012; 56 Suppl 1: S75-S87 [PMID: 22300468 DOI: 10.1016/S0168-8278(12)60009-9]
33. Forner A, Reig ME, de Lope CR, Bruix J. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis 2010; 30: 61-74 [PMID: 20175034 DOI: 10.1055/s-0030-1247133]
34. Chen CH, Hu FC, Huang GT, Lee PH, Tsang YM, Cheng AL, Chen DS, Wang JD, Sheu JC. Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method--analysis of 2010 Taiwanese patients. Eur J Cancer 2009; 45: 1630-1639 [PMID: 19157858]
35. Yang T, Zhang J, Lu JH, Yang LQ, Yang GS, Wu MC, Yu WF. A new staging system for resectable hepatocellular carcinoma: comparison with six existing staging systems in a large Chinese cohort. J Cancer Res Clin Oncol 2011; 137: 739-750 [PMID: 20607551 DOI: 10.1007/s00432-010-0935-3]
36. op den Winkel M, Nagel D, Sappl J, op den Winkel P, Lamerz R, Zech CJ, Straub G, Nickel T, Rentsch M, Stieber P, Göke B, Kolligs FT. Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohort. PLoS One 2012; 7: e45066 [PMID: 23071507 DOI: 10.1371/journal.pone.0045066]
37. Poon RT, Fan ST, Tsang FH, Wong J. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann Surg 2002; 235: 466-486 [PMID: 11923602]
38. Poon D, Anderson BO, Chen LT, Tanaka K, Lau WY, Van Cutsem E, Singh H, Chow WC, Ooi LL, Chow P, Khin MW, Koo WH. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol 2009; 10: 1111-1118 [PMID: 19880065 DOI: 10.1016/S1470-2045(09)70241-4]
39. Wu MC. [Traditional Chinese medicine in prevention and treatment of liver cancer: function, status and existed problems]. Zhongxiyi Jiehe Xuebao 2003; 1: 163-164 [PMID: 15339547]
40. Zhai XF, Chen Z, Li B, Shen F, Fan J, Zhou WP, Yang YK, Xu J, Qin X, Li LQ, Ling CQ. Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: a multicenter randomized controlled trial. J Integr Med 2013; 11: 90-100 [PMID: 23506690 DOI: 10.3736/jintegrmed2013021]
41. Greten TF, Wang XW, Korangy F. Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches. Gut 2015; 64: 842-848 [PMID: 25666193 DOI: 10.1136/gutjnl-2014-307990]
42. Roayaie S, Jibara G, Tabrizian P, Park JW, Yang J, Yan L, Schwartz M, Han G, Izzo F, Chen M, Blanc JF, Johnson P, Kudo M, Roberts LR, Sherman M. The role of hepatic resection in the treatment of hepatocellular cancer. Hepatology 2015; Epub ahead of print [PMID: 25678263 DOI: 10.1002/hep.27745]
43. Vitale A, Burra P, Frigo AC, Trevisani F, Farinati F, Spolverato G, Volk M, Giannini EG, Ciccarese F, Piscaglia F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Cabibbo G, Felder M, Gasbarrini A, Sacco R, Foschi FG, Missale G, Morisco F, Svegliati Baroni G, Virdone R, Cillo U. Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study. J Hepatol 2015; 62: 617-624 [PMID: 25450706 DOI: 10.1016/j.jhep.2014.10.037]
44. Kokudo N. Is it a time to modify the BCLC guidelines in terms of the role of surgery? World J Surg 2015; 39: 469-470 [PMID: 25522897 DOI: 10.1007/s00268-014-2915-2]
45. Zhong JH, Ke Y, Gong WF, Xiang BD, Ma L, Ye XP, Peng T, Xie GS, Li LQ. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma. Ann Surg 2014; 260: 329-340 [PMID: 24096763 DOI: 10.1097/SLA.0000000000000236]
46. Guglielmi A, Ruzzenente A, Conci S, Valdegamberi A, Vitali M, Bertuzzo F, De Angelis M, Mantovani G, Iacono C. Hepatocellular carcinoma: surgical perspectives beyond the barcelona clinic liver cancer recommendations. World J Gastroenterol 2014; 20: 7525-7533 [PMID: 24976693 DOI: 10.3748/wjg.v20.i24.7525]